Head of Hematology Franchise, Pipeline Commercialization Strategy

Head of Hematology Franchise, Pipeline Commercialization Strategy

Abb Vie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas—immunology, oncology, neuroscience, and eye care—within the Allergan Aesthetics portfolio. For more information about Abb Vie, please visit

This leadership position will report to the VP, PCS Oncology and will be an active member of the PCS Oncology leadership team. The Head of Hematology Franchise will act as a thought partner to the leadership team and cross‑functional teams, focusing on developing strategies and tactics to accelerate our leadership in core disease areas within hematological malignancies and expand into adjacent areas.

• In partnership with our early pipeline and BD team, create strategies that enable us to further anchor, bolster, or replace existing anchors within our pipeline in hematological malignancies, including novel technologies, targets, and/or modalities that may not currently be within our pipeline.
• Develop rigor in assessing commercial viability of our pipeline and external opportunities, integrating key insights and competitive landscape data.
• Lead pivotal / enterprise process transformation and capability build for the pipeline commercialization and strategy team (PCS), enabling early brand plan, disease area strategy, and strategic long‑range planning (LRP).

• Develop, champion, and communicate vision and overall strategy to stakeholder groups, gaining commitment and support for portfolio prioritization, asset strategies, and BD investments.
• Understand market, key segment value drivers, growth opportunities, target product profiles, product positioning, and revenue potential for multiple Phase II+ assets/indications within the hem franchise to drive winning portfolio value‑proposition plans and strong P&L investment thesis.
• Define and drive strategic value creation across lifecycle alongside R&D and commercial cross‑functional partners for Abb Vie’s hematology portfolio.
• Partner with the PCS VP to deliver optimal commercial strategies that maximize value across the hem franchise’s assets and integrated portfolio.
• Collaborate with Medical Affairs, Health Impact, Early & Late Clinical Development, and Commercial cross‑functional leaders to develop scientific platforms and drive data generation for target product labels and claims.
• Oversee development and delivery of Target Product Profiles (TPP) within the hem franchise.
• Oversee development of business cases for governance endorsement.
• Identify new value generation for the franchise to unlock further opportunity and accelerate commercialization.
• Drive prioritization of key leverage points in the treatment process and develop behavioral objectives for each stakeholder group.
• Manage risk, opportunity, and issue at strategic and operational levels across the franchise.
• Initiate geo‑strategy and indication prioritization in partnership with R&D, commercial cross‑functional leaders, and affiliates for optimal reimbursement and access strategies.
• Establish strong external networks, engaging clinical experts.
• Exhibit clear and courageous leadership behavior, implementing optimal program structures for timely decisions.
• Partner with Investor Relations to develop and manage external messages for the analyst community.
• Manage partnership & alliance agreements to drive maximum value.
• As a people leader, coach and develop talent, set goals, succession plan, and execute performance management aligned to business KPIs.
• Broaden Abb Vie’s oncology network through scientific, academic, KOL, payer, and patient advocacy relationships.

• Bachelor’s degree required; advanced degree (MBA, Ph.D., or MD) preferred.
• 10–15+ years of progressive commercial leadership experience in the pharmaceutical industry, with recent in‑line operational experience and P&L ownership in the U.S. or other major markets.
• Successful product launch experience preferred.
• Managed care experience preferred.
• Oncology…